[The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
D000328:Adult; D001161:Arteriosclerosis / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D005341:Fibrinolysin / Q000032:analysis; D006496:Heparinoids / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D013925:Thromboplastin / Q000032:analysis; D013927:Thrombosis / Q000517:prevention & control*
D006496:Heparinoids; D008055:Lipids; D013925:Thromboplastin; D002784:Cholesterol; D005341:Fibrinolysin
Effetti della somministrazione orale di un solfopolisaccaride a basso peso molecolare in un gruppo di lavoratori sedentari con cardio-vasculopatia aeteriosclerotica.